Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JD Health InternationalFRA:8ZN -1.36%92 Receivables Turnover is 93.08 as of Dec. 2025. GuruFocus rates FRA:8ZN with a GF Score™ of 92/100 and a GF Value™ of €6.34 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 659 Healthcare Providers & Services companies, JD Health International ranks better than 98.03% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. JD Health International's Revenue for the
six
months ended in Dec. 2025 was €4,626 Mil. JD Health International's average Accounts Receivable for the
six
months ended in Dec. 2025 was €50 Mil.
Hence, JD Health International's Receivables Turnover for the
six
months ended in Dec. 2025 was 93.08.
JD Health International (FRA:8ZN) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
JD Health International Receivables Turnover Related Terms
JD Health International Receivables Turnover Historical Data
* Premium members only.
The historical data trend for JD Health International's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Receivables Turnover Chart
JD Health International Receivables Turnover Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where JD Health International's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International (FRA:8ZN) has a Receivables Turnover of 93.08 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on JD Health International and its competitors. According to the industry distribution chart, JD Health International ranks #13 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 2%.
Is JD Health International's Receivables Turnover too high?
JD Health International's current Receivables Turnover is 93.08. The Healthcare Providers & Services industry median Receivables Turnover is 7.98. JD Health International's value of 93.08 is 1066.4% above this industry median. Based on the distribution chart, JD Health International ranks #13 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, JD Health International has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Receivables Turnover compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #13 out of 659 companies for Receivables Turnover. This places JD Health International in the top 2% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.98. JD Health International's value of 93.08 is 1066.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.98, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current Receivables Turnover of 93.08 is 1066.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current Receivables Turnover is 93.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
Based on GuruFocus' analysis, JD Health International (FRA:8ZN) is currently considered Significantly Undervalued. The stock's GF Value™ is €6.34, compared to a current price of €4.24 — trading 33.1% below its estimated fair value. The current Receivables Turnover is 93.08 and 1066.4% above the Healthcare Providers & Services industry median of 7.98. JD Health International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For JD Health International (FRA:8ZN), the current Receivables Turnover is 93.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (FRA:8ZN) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of €4.24 is trading 33.1% below its estimated GF Value™ of €6.34.
GuruFocus considers JD Health International to be Significantly Undervalued.
Key valuation signals for FRA:8ZN:
Receivables Turnover: 93.08
GF Value™: €6.34 vs. price of €4.24 (33.1% below fair value)
Industry Position: 1066.4% above the Healthcare Providers & Services median (#13 of 659)
No single metric tells the full story. See the FRA:8ZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
92GF Score
Get the complete analysis for FRA:8ZN
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8ZN has been successfully added to your 
